AP NEWS

Global Circulating Tumor Cells (CTC) Market Outlook to 2023: Analysis by Technology, Application and Geography - ResearchAndMarkets.com

September 6, 2018

DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The “Global Circulating Tumor Cells (CTC) Market - Segmented by Technology, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.

The circulating tumor cells (CTC) market is expected to register a growth rate of nearly 9% during the forecast period 2018-2023.The market is expected to grow steadily due to the high prevalence of cancer and increasing demand for preventive medicine with the need for companion diagnostics.North America is estimated to witness high growth rate with high share in this market due to the well-established healthcare infrastructure with high adoption of advanced diagnostic technologies and rising demand of research projects for cancers.

Growing Prevalence of Cancer

The growing prevalence of cancer patients has a direct impact on increased demand for CTC market. Thus, the increasing prevalence of different types of cancers directly benefits the growth of CTC market.

Other driving factors for this market include the development of cluster chip technology for capturing clusters of CTCs, advancements in biomedical imaging and bioengineering technology and increasing demand for preventive medicine and companion diagnostics.

Other HighlightsTechnical Difficulties in Detection and Characterization of CTCsAsia Pacific to Witness the Fastest Growth Rate

Key Developments in the Market

Natera, a company involved in non-invasive genetic testing and the analysis of circulating cell-free DNA, to present successful results of Signatera, to monitor colorectal cancer and identify disease recurrence.Biocept Inc received patent for its Target Selector assays for molecular analysis to improve the patient diagnosis with cancer in China.Companies FeaturedAdvanced Cell Diagnostics Inc.ApoCellAviva BiosciencesBiocept Inc.Cynvenio Biosystems Inc.Clearbridge Biomedics Pte Ltd.Creatv Microtech Inc.Menarini Silicon BiosystemsMiltenyi BiotecQiagenn

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Market Dynamics

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future Market Outlook

For more information about this report visit https://www.researchandmarkets.com/research/mftrsq/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005355/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Biomarkers

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 05:14 AM/DISC: 09/06/2018 05:14 AM

http://www.businesswire.com/news/home/20180906005355/en

AP RADIO
Update hourly